Funds Holding Derma Sciences, Inc.

 
Stock Quotes for Derma Sciences, Inc. top ^
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Distressed
Sign-up for dsci investment picks

 
News Articles for Derma Sciences, Inc. top ^
Products Were Featured In Seven Posters PRINCETON, N.J. , Oct.
Sign-up for Derma Sciences Presented Clinical Evidence And Data On Its Tissue Regeneration Products for Diabetic Foot Ulcers At Fall 2014 Symposium On Advanced Wound Care investment picks
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that on October 31, 2014 the Centers for Medicare and Medicaid Services (CMS) issued the final rule for hospital outpatient prospective payment to take effect January 1, 2015.
Sign-up for Newly Published Final CMS Payments for 2015 Favorably Impact Derma Sciences’ TCC-EZ® and AMNIOEXCEL® investment picks
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on November 10, 2014 to discuss the financial results for the third quarter of 2014.
Sign-up for Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th investment picks
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2014.
Sign-up for Derma Sciences Reports Third Quarter Financial Results investment picks
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that Edward J.
Sign-up for Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum investment picks
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that management will be participating in two upcoming investor conferences.
Sign-up for Derma Sciences To Participate in Two Upcoming Investor Conferences in December investment picks
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, introduces financial guidance for the year ended December 31, 2015 and provides preliminary net sales for the year ended December 31, 2014.
Sign-up for Derma Sciences Introduces 2015 Financial Guidance and Provides 2014 Preliminary Net Sales investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Derma Sciences, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Depomed, Inc.  |  Next: Funds Holding Derwent London PLC